Literature DB >> 7662581

Scleredema adultorum: case report and demonstration of abnormal expression of extracellular matrix genes in skin fibroblasts in vivo and in vitro.

J Varga1, S Gotta, L Li, S Sollberg, M Di Leonardo.   

Abstract

To elucidate the mechanisms involved in the development of cutaneous fibrosis in scleredema adultorum, we studied a patient with long-standing scleredema who had no history of diabetes mellitus or preceding febrile illness. Histological examination of a biopsy specimen from involved forearm skin demonstrated marked thickening of the dermis and accumulation of mucin between collagen bundles. Increased levels of type I collagen mRNA, as evidenced by positive in situ hybridization signals with an alpha 1(I) procollagen cDNA were found in numerous fibroblasts throughout the dermis. The expression of several genes coding for proteins involved in the maintenance of connective tissue was examined by determining in vitro protein production and mRNA levels in fibroblasts from the affected skin. Total protein production, glucosamine incorporation and collagen synthesis, were elevated by 44-97% in scleredema fibroblasts, compared with fibroblasts from two healthy individuals. Levels of mRNAs for alpha 1(I) and alpha 1(III) procollagens and fibronectin were elevated in scleredema fibroblasts, whereas mRNA levels for the tissue inhibitor of metalloproteinase were unaltered compared with control cultures. The results suggest that fibroblasts from the involved skin in non-diabetic patients with scleredema may exhibit a biosynthetically activated phenotype, which persists for several years. These alterations are likely to be involved in the development of the cutaneous induration and thickening which is characteristic of this disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7662581     DOI: 10.1111/j.1365-2133.1995.tb16962.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  6 in total

Review 1.  Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review.

Authors:  Caterina Ferreli; Giulia Gasparini; Aurora Parodi; Emanuele Cozzani; Franco Rongioletti; Laura Atzori
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 8.667

2.  Scleredema diabeticorum partially treated with low-dose methotrexate: a report of five cases.

Authors:  Asena Çiğdem Doğramacı; Mehmet Uğur Inan; Esin Atik; Cumali Gökçe
Journal:  Balkan Med J       Date:  2012-06-01       Impact factor: 2.021

3.  Scleredema adultorum of Buschke over an unusual site associated with pregnancy.

Authors:  C Sujatha Vinod; H Ambika; Hariharasubramony Ambika; Nithya Reddy; Jayantha Kumar De
Journal:  Indian Dermatol Online J       Date:  2014-10

4.  MDI 301, a synthetic retinoid, depressed levels of matrix metalloproteinases and oxidative stress in diabetic dermal fibroblasts.

Authors:  Jianhua Zhai; Yuli Wang
Journal:  Oncotarget       Date:  2017-07-04

5.  Myricetin, a potent natural agent for treatment of diabetic skin damage by modulating TIMP/MMPs balance and oxidative stress.

Authors:  Zijian Wu; Xuemin Zheng; Min Gong; Ying Li
Journal:  Oncotarget       Date:  2016-11-01

6.  Scleredema Diabeticorum with unusual presentation and fatal outcome.

Authors:  Francisco J Ruiz Miyares; Renju Kuriakose; Dirk T Deleu; Naghi Abd El-Wahad; Hassan Al-Hail
Journal:  Indian J Dermatol       Date:  2008       Impact factor: 1.494

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.